MeSH Browser

MeSH Supplementary: MP regimen
Unique ID: C065095
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C065095
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Methotrexate
Frequency: 7
Note: chemotherapy protocol consisting of above cpds; used in the treatment of advanced bladder cancer; do not confuse with MP protocol (melphalan & prednisone) nor with MP combination (melphalan & prednisolone)
Source: Arch Ital Urol Nefrol Androl 1990;62(2):243
Date of Entry: 1990/08/29
Revision Date: 2000/11/30

MP regimen MeSH Supplementary Concept Data 2025